Comparison of beta-adrenergic blocking activities of propranolol, isopropylmethoxamine, sotalol, practolol, alprenolol, pindolol, oxprenolol and D-32 in the atria and trachea of the guinea-pig.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000526:Alprenolol / Q000494:pharmacology*; D000818:Animals; D002082:Butylamines / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004558:Electric Stimulation; D005260:Female; D006168:Guinea Pigs; D006325:Heart Atria / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects; D066298:In Vitro Techniques; D008297:Male; D008729:Methoxamine / Q000031:analogs & derivatives* / Q000494:pharmacology; D009119:Muscle Contraction / Q000187:drug effects; D009130:Muscle, Smooth / Q000187:drug effects*; D010096:Oxprenolol / Q000494:pharmacology*; D010647:Phenyl Ethers / Q000494:pharmacology; D010869:Pindolol / Q000494:pharmacology*; D011217:Practolol / Q000494:pharmacology*; D011412:Propanolamines / Q000494:pharmacology*; D011433:Propranolol / Q000494:pharmacology*; D011955:Receptors, Drug / Q000187:drug effects; D013015:Sotalol / Q000494:pharmacology*; D014132:Trachea / Q000187:drug effects
D000319:Adrenergic beta-Antagonists; D002082:Butylamines; D010647:Phenyl Ethers; D011412:Propanolamines; D011955:Receptors, Drug; D010096:Oxprenolol; D000526:Alprenolol; D011433:Propranolol; D013015:Sotalol; D010869:Pindolol; D008729:Methoxamine; D011217:Practolol